Q2 2022 Holdings
Filed 2022-08-15 | 79 holdings | $397.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bionomics Limited(BNOXN) | ADS | 09063M205 | $555 | 80,971 | 0.0% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $616 | 190,815 | 0.0% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $818 | 847,879 | 0.0% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $827 | 140,000 | 0.0% |
| Angion Biomedica Corp | COM | 03476J107 | $1.2K | 1,071,297 | 0.0% |
| Galmed Pharmaceuticals LTD(GLMD) | SHS | M47238106 | $1.2K | 1,799,694 | 0.0% |
| Aileron Therapeutics Inc(ALRNEUR) | COM | 00887A105 | $1.4K | 5,265,555 | 0.0% |
| Erytech Pharma | SPONSORED ADR | 29604W108 | $1.4K | 1,314,656 | 0.0% |
| MEI Pharma Inc | COM NEW | 55279B202 | $2.1K | 3,532,057 | 0.0% |
| Forward Pharma A/S | SPONSORD ADS NEW | 34986J204 | $2.2K | 513,791 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | COM | 816212104 | $2.3K | 1,723,133 | 0.0% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $2.3K | 3,089,615 | 0.0% |
| Molecular Partners AG(MOLN) | ADS | 60853G106 | $3.0K | 443,221 | 0.0% |
| Elevation Oncology Inc | COM | 28623U101 | $3.2K | 2,312,200 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $3.4K | 6,861,127 | 0.0% |
| Inventiva SA(IVA) | ADS | 46124U107 | $4.0K | 686,040 | 0.0% |
| Infinity Pharmaceuticals Inc(INFIQ) | COM | 45665G303 | $4.0K | 6,353,645 | 0.0% |
| Hillevax Inc | COM | 43157M102 | $4.2K | 382,513 | 0.0% |
| Molecular Templates Inc | COM | 608550109 | $4.6K | 4,996,565 | 0.0% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $5.7K | 2,326,710 | 0.0% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $5.7K | 9,544,262 | 0.0% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $7.0K | 2,938,851 | 0.0% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $7.9K | 666,666 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $8.8K | 1,106,838 | 0.0% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $9.5K | 5,080,320 | 0.0% |
| Generation BIO Co(GBIOGBX) | COM | 37148K100 | $10.3K | 1,556,032 | 0.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $10.9K | 1,275,240 | 0.0% |
| Ikena Oncology Inc | COM | 45175G108 | $11.1K | 2,503,071 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $11.7K | 3,698,629 | 0.0% |
| Contrafect Corp(CFRXUSD) | COM NEW | 212326300 | $12.2K | 3,972,300 | 0.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $12.6K | 3,898,000 | 0.0% |
| Calliditas Therapeutics AB | SPONSERED ADS | 13124Q106 | $13.5K | 750,000 | 0.0% |
| Viracta Therapeutics Inc | COM | 92765F108 | $14.0K | 3,614,662 | 0.0% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $14.7K | 6,851,051 | 0.0% |
| Concert Pharmaceuticals Inc(CNCEEUR) | COM | 206022105 | $15.3K | 3,629,000 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $16.2K | 926,529 | 0.0% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $17.7K | 2,472,327 | 0.0% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $18.0K | 1,470,334 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $18.0K | 3,447,946 | 0.0% |
| Rain Therapeutics Inc | COM | 75082Q105 | $19.6K | 3,526,729 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $20.2K | 1,744,012 | 0.0% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $22.6K | 1,666,282 | 0.0% |
| Point Biopharma Global Inc | COM | 730541109 | $22.9K | 3,367,826 | 0.0% |
| Verastem Inc | COM | 92337C104 | $23.2K | 19,974,658 | 0.0% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $26.3K | 14,149,179 | 0.0% |
| AC Immune SA(ACIU) | SHS | H00263105 | $26.8K | 7,428,379 | 0.0% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $28.0K | 4,007,413 | 0.0% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $31.0K | 7,611,503 | 0.0% |
| Cincor Pharma Inc | COM | 17240Y109 | $31.0K | 1,644,393 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $31.5K | 1,659,220 | 0.0% |